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Abstract
Nicotinamide nucleotide transhydrogenase, NNT, is a ubiquitous protein of the 
inner mitochondrial membrane with a key role in mitochondrial redox balance. NNT 
produces high concentrations of NADPH for detoxification of reactive oxygen species 
by glutathione and thioredoxin pathways. In humans, NNT dysfunction leads to an 
adrenal-specific disorder, glucocorticoid deficiency. Certain substrains of C57BL/6 mice 
contain a spontaneously occurring inactivating Nnt mutation and display glucocorticoid 
deficiency along with glucose intolerance and reduced insulin secretion. To understand 
the underlying mechanism(s) behind the glucocorticoid deficiency, we performed 
comprehensive RNA-seq on adrenals from wild-type (C57BL/6N), mutant (C57BL/6J) 
and BAC transgenic mice overexpressing Nnt (C57BL/6JBAC). The following results were 
obtained. Our data suggest that Nnt deletion (or overexpression) reduces adrenal 
steroidogenic output by decreasing the expression of crucial, mitochondrial antioxidant 
(Prdx3 and Txnrd2) and steroidogenic (Cyp11a1) enzymes. Pathway analysis also revealed 
upregulation of heat shock protein machinery and haemoglobins possibly in response 
to the oxidative stress initiated by NNT ablation. In conclusion, using transcriptomic 
profiling in adrenals from three mouse models, we showed that disturbances in adrenal 
redox homeostasis are mediated not only by under expression of NNT but also by its 
overexpression. Further, we demonstrated that both under expression or overexpression 
of NNT reduced corticosterone output implying a central role for it in the control of 
steroidogenesis. This is likely due to a reduction in the expression of a key steroidogenic 
enzyme, Cyp11a1, which mirrored the reduction in corticosterone output.
Background
Adrenal insufficiency is a rare, potentially fatal, endocrine 
disorder resulting from a failure of the adrenal cortex to 
respond to hormonal stimuli. In familial (or isolated) 
glucocorticoid deficiency, adrenal hormone output is 
preserved apart from a specific deficit of glucocorticoids. 
Normally, under the control of hypothalamic 
corticotropin-releasing hormone (CRH) and arginine 
vasopressin (AVP), the pituitary releases adrenocorticotropic 
hormone (ACTH), which acts on the adrenal via the 
ACTH receptor (otherwise known as MC2R) to produce 
glucocorticoids, mainly cortisol. This in turn acts on the 
hypothalamus and pituitary to suppress further production 
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of ACTH in a negative feedback loop (Fig. 1A) (Keller-Wood 
& Dalman 1984). The human adult adrenal is characterised 
by three distinctive cortical zones surrounding the medulla; 
the zona glomerulosa (ZG) where mineralocorticoids are 
produced, the zona fasciculata (ZF), which synthesises 
glucocorticoids (mostly cortisol; in mice, the major 
glucocorticoid is corticosterone) and the zona reticularis 
(ZR) where androgen synthesis occurs (Vinson 2003). 
The first step of steroidogenesis occurs once cholesterol 
is transported from the outer to the inner mitochondrial 
membrane by the steroidogenic acute regulatory protein 
(STAR) and is converted to pregnenolone by the cholesterol 
side chain cleavage enzyme (CYP11A1). To make cortisol, 
pregnenolone then undergoes a series of intermediate 
reactions catalysed by microsomal enzymes (CYP17A1, 
HSD3B2 and CYP21A2) before the final step of cortisol 
production, catalysed by 11beta-hydroxylase (CYP11B1) 
or aldosterone production, catalysed by CYP11B2, both 
occurring in mitochondria (Fig.  1B) (Miller & Auchus 
2011). The activities of steroidogenic cytochrome P450 
(CYP) enzymes are reliant upon electron-donating redox 
partners; for mitochondrial (or type 1) enzymes, electrons 
are transferred from the reduced form of nicotinamide 
adenine dinucleotide phosphate (NADPH) by ferredoxin 
reductase (FDXR) and ferredoxin (FDX1), whereas the 
microsomal enzymes (Type 2) use P450 oxidoreductase 
(POR) as their redox partner. Hence, the first and last 
steps of cortisol production occur in the mitochondria 
and require a constant supply of reductant NADPH. This 
NADPH is regenerated from NADP by a few pathways 
including the thioredoxin and glutathione pathways, 
which are ultimately enabled by NNT (Fig. 2).
Perturbations in this pathway cause a number of 
steroidogenic defects affecting adrenal and gonadal 
steroidogenesis. STAR mutations give rise to lipoid 
congenital adrenal hyperplasia (OMIM 201710), a 
severe syndrome of adrenal and gonadal insufficiency 
resulting in XY sex reversal; CYP11A1 defects give a 
similar clinical picture but without the lipid build up in 
steroidogenic tissues seen with STAR mutations. HSD3B2, 
CYP17A1, CYP21A2, CYP11B1 and POR mutations give 
rise to four variants of congenital adrenal hyperplasia 
(OMIM 201810, 202110, 201910, 202010, and 201750 
respectively) and CYP11B2 mutations give rise to 
hypoaldosteronism (OMIM 203400) (Fig.  1B) (Miller & 
Auchus 2011). No mutations have yet been described 
in humans in FDXR/FDX1 – perhaps due to embryonic 
lethality. Partial loss-of-function changes in STAR and 
CYP11A1 can present with a less severe phenotype akin to 
our disease of interest, familial or isolated glucocorticoid 
deficiency (FGD) (Baker et al. 2006, Metherell et al. 2009, 
Rubtsov et al. 2009, Sahakitrungruang et al. 2010, 2011, 
Parajes et al. 2011). In FGD, the two most common gene 
defects are mutations in the melanocortin 2 receptor and 
its accessory protein (MC2R and MRAP), but recently, 
we have described defects in NADPH supply to and/or 
antioxidant defence in mitochondria, with defects in two 
Figure 1
Hypothalamic–pituitary–adrenal (HPA) axis and enzymes responsible for 
cortisol production. (A) The HPA axis is a major component for 
adaptation of the stress response and cortisol release and consists of a 
complex set of feedback interactions that connect the central nervous 
and endocrine systems. In response to stress the paraventricular nucleus 
of the hypothalamus releases corticotropin-releasing hormone (CRH) and 
arginine vasopressin (AVP) that acts on the adrenal to stimulate 
glucocorticoid synthesis. (B) The conversion of cholesterol to cortisol is 
achieved by a series of catalytic reactions catalysed by mitochondrial 
(in blue) and microsomal (in pink) enzymes. Mutations in these key 
steroidogenic enzymes result in diseases of adrenal and gonadal 
insufficiency, indicated to the right with their reference numbers from 
online inheritance in man (OMIM). STAR, steroidogenic acute regulatory 
protein; CYP11A1, cytochrome P450 side chain cleavage enzyme; 
CYP17A1, 17-alpha hydroxylase; HSD3B2, 3-beta hydroxysteroid 
dehydrogenase, CYP21A2, 21-hydroxylase; LCAH, lipoid congenital 
adrenal hyperplasia; FGD, familial glucocorticoid deficiency; CAH, 
congenital adrenal hyperplasia.
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genes, NNT and thioredoxin reductase 2 (TXNRD2), giving 
disorders of adrenal insufficiency primarily compromising 
glucocorticoid production (Meimaridou et al. 2012, 2013, 
Prasad et al. 2014). MC2R and MRAP are adrenal zone and 
ACTH pathway specific, so it is unsurprising that they 
give rise to isolated glucocorticoid deficiency, whereas 
NNT and TXNRD2 are ubiquitously expressed.
NNT is the major mitochondrial enzymatic source 
of NADPH contributing 45% of the total NADPH supply 
(Nickel et al. 2015). It exists as a dimer and spans the inner 
mitochondrial membrane modulating H+ movement and 
supplying the high concentrations of NADPH required for 
the detoxification of ROS by glutathione and thioredoxin 
pathways (Fig. 2). Even though the gene is ubiquitously 
expressed, the organ specific physiological roles of NNT are 
only gradually being revealed by the study of a C57BL/6J 
mouse substrain that has a spontaneous mutation in Nnt 
(an in-frame 5-exon deletion), resulting in the truncation 
of the message and absence of the protein (Nickel et al. 
2015). The first consequence of this murine Nnt deletion, 
described by Toye and coworkers in 2005, was glucose 
intolerance and reduced insulin secretion (Toye et  al. 
2005). Subsequent to the finding of human mutations 
causing FGD, we showed that 3-month-old mice had 50% 
lower basal and stimulated levels of corticosterone than 
their wild-type counterparts. Histological examination 
of their adrenals revealed a slightly disorganized ZF with 
higher levels of apoptosis than the wild-type C57BL/6N 
strain (Meimaridou et  al. 2012). More recently, it was 
reported that liver mitochondria from C57BL/6J mice 
have major redox impairments resulting in an inability 
to maintain NADP and glutathione in their reduced states 
(Ronchi et al. 2013).
Previously, we have shown that H295R cells where Nnt 
has been stably knocked down undergo oxidative stress 
as demonstrated by low glutathione levels, and increased 
mitochondrial superoxide production (Meimaridou et al. 
2012). Similar defects in energy metabolism due to Nnt 
ablation have also been demonstrated in other mouse 
tissues (heart, liver, pancreas) emphasising the importance 
of NNT for cellular bioenergetics (Sauer et al. 2004, Ronchi 
et al. 2013, Nickel et al. 2015). However, the mechanism 
by which loss of Nnt causes the adrenal-specific pathology 
we observe is unclear.
Here, we aim to investigate the effect of NNT loss 
and overexpression in the adrenal cortex by performing 
RNA-seq on adrenals from mice, which are wild-
type (C57BL/6N, Nnt+/+), null (C57BL/6J, Nnt−/−) or 
2-fold overexpressors (BAC transgenic, NntBAC) of Nnt 
(Freeman et al. 2006).
Materials and methods
Mouse strains
All mice were bred, housed and culled at MRC Harwell and 
therefore the husbandry was identical for all 3 substrains. 
The mouse strains used were C57BL/6NHsd originally 
Figure 2
Detoxification of free radicals in the 
mitochondria. NNT encodes a protein, integral to 
the inner mitochondrial membrane, which under 
normal physiological conditions uses energy from 
the mitochondrial proton gradient to generate 
high concentrations of NADPH. This is required 
for many processes in the cell including the 
supply of reductive power to a network of 
antioxidant enzymes, specifically the glutathione 
(GSH/GSSG) and thioredoxin (Trx(SH)2/TrxS2) 
systems, to allow the detoxification of H2O2. 
Manganese superoxide dismutase (MnSOD) 
converts O2·− into H2O2 and protects ROS-sensitive 
proteins from oxidative damage. H2O2 is then 
removed by glutathione peroxidases (e.g. GPX1) 
or peroxiredoxins (e.g. PRDX3) using GSH and 
Trx(SH)2 as co-factors. GSH and Trx(SH)2 can be 
regenerated by glutathione reductase (GR) and 
thioredoxin reductase-2 (TXNRD2), respectively, 
using the reducing power from NADPH. Without 
NNT, the production of NADPH is compromised, 
causing the mitochondria to become more 
sensitive to oxidative stress. Enzymes underlined 
in red are affected by one or more mutations in 
FGD patients.
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from Harlan (Harlan Laboratories UK), which is wild type 
for Nnt (Nnt+/+), C57BL/6J originally from Charles River 
(Charles River UK), which has an in-frame deletion of 
5 Nnt exons (Nnt−/−) and C57BL/6J mice carrying a BAC 
transgene to restore murine Nnt (NntBAC; Freeman et  al. 
2006), which we show are 2-fold overexpressors. For 
RNA-seq, 18-month-old male mice of the three different 
substrains were utilised, 5 mice per group. Mice were culled 
with an overdose of Euthatal (to allow for the collection 
of blood) and tissues were then removed quickly and 
either fixed or flash frozen in liquid nitrogen. All mice 
were culled between 10:00 and 11:30 h and adrenals were 
removed. The animal protocols used in this study were 
approved by United Kingdom Home Office.
Genotyping
Genomic DNA was extracted from the mouse tail tissue 
using a Qiagen DNeasy tissue kit. Mice were genotyped 
for Nnt status using previously published primers (Huang 
et al. 2006).
Mouse histology
Mouse adrenals from Nnt+/+, Nnt−/− and NntBAC were 
fixed in 4% paraformaldehyde (Sigma) and embedded 
in paraffin. Sections were obtained using a microtome 
(Microm HM 325, Thermo Fisher) at 6-μm thickness, and 
hematoxylin & eosin (H&E) staining was performed using 
standard procedures (Guasti et al. 2011).
To assess changes in lipid content between the three 
mice strains, we performed Oil Red O staining as described 
previously (www.ihcworld.com/_protocols/special_stains/
oil_red_o.htm). Briefly sections of fresh frozen adrenal 
tissues were obtained at 5 µm thickness and fixed in ice 
cold 10% formalin for 5 min. Sections were air dried and 
placed in absolute propylene glycol for 5 min to avoid 
carrying water into Oil Red O. Sections were then stained 
with pre-warmed Oil Red O solution for 8–10 min at 60°C 
and then washed twice with distilled water. Images were 
acquired using a Leica DMR microscope (Leica), and 
digital images were captured using a Leica DC200 camera 
(Leica) and DCViewer software (Leica).
Steroid profile
Serum steroids were quantified using liquid 
chromatography–tandem mass spectrometry (LC–MS/MS) 
as previously described (O’Reilly et al. 2014). Steroids were 
extracted from 200 µL of serum (after addition of internal 
standard) using 1 mL tert-butyl methyl ether (MTBE). After 
freezing at −20°C for 1 h, the MTBE layer was transferred 
into a 96-well plate and evaporated under nitrogen at 
55°C. Samples were reconstituted in 125 µL of a 50:50 
solution of methanol (Sigma) and H2O (Sigma). Steroids 
were analysed on a Waters Xevo with Acquity uPLC, 
steroids were eluted from a HSS T3 1.8 µm, 1.2 × 50 mm 
column with a methanol/water 0.1% formic acid gradient 
system. Two mass transitions were used to identify and 
quantify each steroid (corticosterone: 347.2 > 121.2 and 
347.2 > 97; deoxycorticosterone: 331 > 97 and 331 > 109.
Generation of stable NNT knockdown (KD) and 
scrambled (SCR) H295R cell lines
Lentiviral plasmids (RHS4430-98851990; RHS4430-
98913600; RHS4430-98524425; RHS4430-101033169 
RHS4430-101025114) were obtained from OpenBiosystems 
in a p.GIPZ backbone and contained shRNA specific 
for human NNT (NM 012343) under the control of the 
CMV promoter, plus the puromycin resistance and 
green fluorescence protein (GFP) genes. HEK293T cells 
(packaging cells) were transiently transfected with 
the shRNA plasmids, two days after transfection virus 
containing media was collected, filtered using a 0.22 µm 
filter and used to transduce H295R cells. Four days after 
infection GFP-positive cells were selected in 4 µg/mL 
puromycin. Transduction efficiency was determined by 
fluorescence microscopy. A scrambled (control) cell line 
was generated in a similar fashion using a non-specific 
shRNA.
NADP/NADPH assay
To measure total and reduced nicotinamide adenine 
dinucleotide phosphates (NADP+ and NADPH 
respectively) stably transfected H295R cells were plated 
onto white-walled and white bottomed 96-well culture 
dishes (Corning Costar). After 24 h, NADP+ and NADPH 
were measured using NADP/NADPH-Glo assay (Promega), 
a luminescence-based system and according to the 
manufacturer’s protocol. Luminescence was recorded 
after 15 min using Omega Luminometer (BMGLabTech) 
and with integration time of 0.5 s.
Oxygen consumption rate-XF extracellular 
flux analyser
Scrambled (SCR) and stable knockdown H295R cells 
(NNT-KD) were cultured on Seahorse XF-96 microplates 
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and allowed to grow overnight. On the day of metabolic 
flux analysis, cells were changed to unbuffered DMEM 
(DMEM base medium supplemented with 10 mM 
glucose, 1 mM sodium pyruvate, 2 mM l-glutamine, pH 
7.4) and incubated at 37°C in a non-CO2 incubator for 
1 h. All medium and injection reagents were adjusted to 
pH 7.4 on the day of assay. Baseline measurements of 
oxygen consumption rate (OCAR, measured by oxygen 
concentration change) and extracellular acidification 
rate (ECAR, measured by pH change) were taken before 
sequential injection of treatments/inhibitors: oligomycin 
(ATP synthase inhibitor, 4 µM), FCCP (mitochondrial 
respiration uncoupler, 1 µM) and rotenone (Complex I 
inhibitor, 1 µM).
RNA-seq
RNA from mouse adrenal tissues (Nnt+/+, Nnt−/−, NntBAC) 
was extracted using the RNeasy Mini kit (Qiagen). Once 
RNA quality and concentration were tested, samples were 
processed by Oxford Gene Technology (www.ogt.co.uk). 
Enrichment and library preparation were performed using 
Illumina TruSeq RNA Sample Prep Kit, v2; total RNA was 
captured with oligo-dT-coated magnetic beads. The mRNA 
was fragmented and then first-strand cDNA synthesis 
was initiated from random primers, followed by second-
strand synthesis. After end-repair, phosphorylation and 
A-tailing, adapter ligation and PCR amplification were 
performed to prepare the library for sequencing. Paired-
end sequencing was performed over 100 cycles on the 
Illumina HiSeq2000 platform using TruSeq v3 chemistry. 
Fastq files were generated from the sequencing platform 
via the manufacturer’s proprietary software. For mapping 
and alignment, reads were processed through Tuxedo 
suite (Trapnell et  al. 2013). Reads were mapped to their 
location on the appropriate Illumina iGenomes build 
using Bowtie, and splice junctions were identified using 
Tophat. Cufflinks was used to perform transcript assembly, 
abundance estimation and differential expression and 
regulation for the samples. RNA-Seq alignment metrics 
were generated using Picard.
Lipid peroxidation assay
Lipid peroxidation in mouse adrenal lysates was assessed 
by using a lipid peroxidation assay kit (Abcam) based on 
the detection of malondialdehyde (MDA) in the samples. 
Adrenal tissues from Nnt+/+, Nnt−/− and NntBAC mice were 
excised and homogenised in MDA lysis buffer provided 
in the kit. Lysates were then centrifuged at 13,000 g 
for 10 min and the supernatant was collected for lipid 
peroxidation measurements. Samples were incubated 
with thiobarbituric acid (TBA), which interacts with MDA 
present in the samples to generate MDA-TBA adducts. 
These adducts were quantified colorimetrically at 532 nm.
Immunoblotting analysis
Immunoblotting was used to assess protein expression. 
Cells were lysed in RIPA buffer containing protease 
and phosphatase inhibitors (SIGMA) and then left on 
ice for 30 min. Samples were centrifuged for 15 min at 
17,000 g. Supernatant was collected and an equal volume 
of Laemmli buffer was added. Samples were heated at 
95–100°C for 5 min and then loaded on 4–12% SDS gels. 
Protein separation was performed by using the Invitrogen 
electrophoresis system. Proteins were then transferred to 
nitrocellulose membrane (Sigma Aldrich) using semi-dry 
transfer blot (Biorad) at 15 V for 1 h. Membranes were 
probed with one of mouse anti-Nnt (1:1000; SIGMA, 
HPA004829), mouse anti-actin (1:5000; SIGMA, A5441), 
rabbit anti-TXNRD2 (1:1000;SIGMA, SAB2702064), rabbit 
anti-PRDX3 (1:500; ProteinTech, 55087-1-AP), rabbit 
anti-GPX1 (1:500; Abcam ab108429), mouse anti-STAR 
(1:1000; Abcam, ab58013), rabbit anti-CYP11A1 (1:1000; 
Cell Signalling, 14217), rabbit anti-HSD3B2 (1:500; Aviva 
Biosystems, OAGA02009) or rabbit anti-CYP21A2 (1:500; 
SIGMA HPA053371). Visualisation of the proteins was 
performed by using Alexa-Fluor 680 and 800 secondary 
antibodies (1:5000; Invitrogen) and the Li-CoR Odyssey 
system.
Statistics
Statistical analyses were performed using a combination 
of one-way ANOVA using Tukey HSD (honest significant 
difference) test and a two-tailed Student’s t-tests assuming 
unequal variance in 5 mice per group. All values were 
expressed as a mean ± s.e.m., and P values <0.05 were 
considered significant.
Results
Mouse phenotyping
We have previously reported that 3-month-old mice 
carrying a spontaneous Nnt 5-exon deletion (C57BL/6J, 
Nnt−/−) have significantly lower levels of corticosterone 
(50%) than their wild-type counterparts (C57BL/6N, 
Nnt+/+) (Meimaridou et  al. 2012). To identify the 
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mechanism by which loss of NNT affects steroidogenesis 
we employed the same mouse models but also included 
an additional mouse line where the Nnt loss had been 
rescued in C57BL/6J mice by transgenic expression 
of the entire murine Nnt gene contained within a 
bacterial artificial chromosome (BAC transgenic, NntBAC) 
(Freeman et al. 2006).
Glucocorticoid levels in the three mouse strains
The adrenal steroid output of the three mouse strains 
was measured at 18  months in murine serum samples 
employing liquid chromatography–tandem mass 
spectrometry (LC–MS/MS). Changes in steroid production 
were observed predominantly for corticosterone, with 
reduction to 14% of wild-type levels in Nnt−/− mice 
(Fig.  3A). Corticosterone levels in the NntBAC mice 
restored serum corticosterone in part, but only to 40% of 
wild-type (Nnt+/+) levels, suggesting that overexpression of 
Nnt also perturbs steroidogenesis. 11-Deoxycorticosterone 
levels were not significantly different among the mice 
and therefore the ratio of 11-deoxycorticosterone/
corticosterone was significantly higher in Nnt−/− and 
NntBAC mice indicating lower enzyme activity of Cyp11b1 
(Fig.  3B). We also noted that, over time, the deficit in 
glucocorticoid output worsened for the Nnt−/− mice, 
between 3 and 18 months corticosterone levels in Nnt+/+ 
were unaltered, whereas there is a 60% decrease for Nnt−/− 
mice, suggesting progressive loss of function (Fig. 3C).
No changes to adrenal histology
In humans with FGD, there is a specific loss of 
glucocorticoid output from the ZF and relative 
preservation of steroid output from the other zones 
suggesting loss of this specific zone. Consistent with 
Figure 3
Biochemical and phenotypic characterisation of Nnt+/+, Nnt−/− and NntBAC mice. (A) Serum corticosterone in Nnt+/+, Nnt−/− and NntBAC mice was measured 
by LC–MS/MS and showed 80% and 50% reduction in Nnt−/− and NntBAC mice, respectively. (B) The 11-deoxycorticosterone (DOC)/corticosterone ratio 
(CYP11B1 inhibition) was significantly higher in Nnt−/− and NntBAC than Nnt+/+ mice. (C) Corticosterone synthesis deteriorates in 18 months Nnt−/− mice 
whereas there is no significant difference in the levels between 3 and 18 month Nnt+/+ mice. (D) H&E staining of mouse adrenals showed no major 
histological differences in architecture or zonation (left panel) and (E) Oil Red O staining revealed no difference in lipid content of the adrenals among 
the three mouse strains (right panels). Results are means ± standard deviation (s.d.); n = 5 mice per group, *P < 0.05, **P < 0.01, ***P < 0.001.
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these findings, Mc2r−/− mice have smaller adrenals 
with preservation of ZG and medulla but atrophied ZF 
(Chida et  al. 2007). Interestingly all Mc2r−/− mice on a 
pure C57BL/6J background die within two days of birth 
whereas those on a mixed B6/Balbc have much higher 
survival rates, with half making it to adulthood perhaps 
due to the restoration of Nnt levels (Chida et al. 2009), 
making Nnt a genetic modifier of their adrenal phenotype 
akin to the situation in another mouse model where NNT 
has a protective role in superoxide dismutase deficient 
mice (Huang et al. 2006). To determine whether loss of 
ZF occurs in Nnt−/− mice we performed H&E staining in 
adrenal sections from the three mouse substrains. This 
showed no morphological differences among the strains 
in adrenal zonation (Fig. 3D). This was supported by the 
finding that genes differentially expressed between zones 
were not altered (see below). This suggested no major 
remodelling of the adrenals due to NNT loss and gave us 
confidence that the RNA-seq variations were not due to 
changes in zonation. Furthermore, on Oil Red O staining, 
we observed no differences in lipid levels between the 
mouse strains suggesting there is neither a dearth of 
cholesterol supply for steroidogenesis nor a surplus due to 
a cholesterol transport defect as seen with Star mutations 
(Sasaki et al. 2008) (Fig. 3E).
Nnt deletion causes oxidative stress in 
mouse adrenals
We measured lipid peroxidation (LPO) by a 
malondialdehyde (MDA) assay as a measure of oxidative 
stress in these mice (5 mice per group). There was a 
significant increase in LPO in the adrenals of Nnt−/− mice 
which returned towards wild-type levels in NntBAC mice 
indicating lipid damage by free radicals in adrenals upon 
Nnt deletion (Fig.  4A). We saw the same trend in H2O2 
levels (increased in Nnt−/− and reduced again in NntBAC) 
(data not shown).
Impaired redox homeostasis caused by lack of NNT 
was further supported by in vitro studies in human 
adrenocortical H295R cells. The total cellular NADP/
NADPH ratio was significantly higher in H295R with 
lentiviral knockdown of NNT (NNT-KD) compared to 
scrambled control cells (SCR), suggesting that NNT is 
required to maintain the redox state of the intracellular 
NADPH and NADP+ pools (Fig. 4B).
The perturbation in NADP/NADPH balance affected 
mitochondrial respiration resulting in significantly lower 
oxygen consumption rates (OCAR) in cells where NNT is 
knocked down (Fig. 4C).
Figure 4
Oxidative stress on NNT ablation. (A) Lipid peroxidation represented by 
MDA levels were measured in adrenals of Nnt+/+, Nnt−/− and NntBAC mice. 
MDA levels were significantly increased in the adrenals of Nnt−/− mice 
with a partial rescue in NntBAC mice indicating lipid damage by free 
radicals in adrenals upon Nnt deletion (B) The cellular levels of NADP/
NADPH in H295R cells with a stable knockdown of NNT (NNT-KD) were 
measured by using a luciferin based assay. Total cellular NADP/NADPH 
ratio was significantly higher in NNT-KD compared to scramble (SCR), 
suggesting that NNT is required to maintain the redox state of the 
intracellular NADPH and NADP+ pools. (C) Mitochondria respiration was 
assessed by measuring oxygen consumption rates using Seahorse XF-96 
metabolic Flux Analyser. NNT-KD cells had a significantly lower basal 
OCAR compared to scrambled cells; the addition of oligomycin 
(complex V inhibitor) resulted in an OCAR decline which was significantly 
lower in NNT-KD cells compared to controls, indicating that the ATP 
turnover was compromised in NNT-KD cells. Furthermore, maximal 
respiration capacity as measured by the addition of an uncoupling agent, 
FCCP, was also significantly lower in NNT-KD cells. The addition of 
rotenone and antimycin (complex I and II inhibitors respectively) 
reflecting the spare respiratory capacity of the cells resulted in a 
reduction of OCAR which was significantly lowered in NNT-KD cells when 
compared to scrambled cells. OCAR values were normalised to total 
protein concentration. Results are means ± standard deviation (s.d.); 
n = 5 per group, *P < 0.05, **P < 0.01, ***P < 0.001.
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Transcriptome profiling by RNA-seq in adrenals  
from the C57BL/6 mouse substrains
To investigate the cause of the reduced steroid 
production upon Nnt deletion, RNA was extracted 
from Nnt+/+, Nnt−/−, and NntBAC mouse adrenals and the 
transcriptome profiled by RNA-seq. Using an Illumina 
HiSeq 2000 sequencer we obtained an average of 
30 million reads per sample, with ~98% of these reads 
mapped to the mouse reference genome. In total, 
27,622 genes were analysed in Nnt+/+, Nnt−/− and NntBAC 
adrenals (Fig. 5A and Supplementary Table 1, see section 
on supplementary data given at the end of this article). 
The most highly expressed categories of genes were 
mitochondrially encoded electron transport chain genes 
(mt-Co1, mt-Co2, mt-Atp6, mt-Co3, mt-Cytb, mt-Nd4, 
mt-Nd2, mt-Nd1, mt-Atp8, mt-Nd6, mt-Nd5, mt-Nd4l, 
mt-Nd3, mt-Rnr1), followed by steroid pathway genes 
Star, Cyp21a1 and Hsd3b1, which are high up in the 
steroidogenic cascade (Supplementary Table 1) perhaps 
reflecting the high mitochondrial content of and high 
demand for steroidogenesis in the adrenal.
Initial data analysis was performed between paired 
samples comparing Nnt+/+ and Nnt−/−, Nnt+/+ and NntBAC 
and Nnt−/− and NntBAC adrenals. To identify differentially 
expressed genes from each group we used the following 
criteria; (1) gene expression level greater than or equal 
to 1 read per kilobase of exon per million fragments 
mapped (RPKM) in all samples; (2) change in expression 
level greater than or equal to 1.5-fold; and (3) significance 
P value <0.05. This revealed differential expression (fold 
change ≥1.5; P < 0.05) of 400 genes in total in the pairwise 
comparisons (Fig. 5B, C and Supplementary Table 2). Only 
1 gene varied between all three pairwise analyses and that 
was Nnt itself (see below and Fig. 5C). We hypothesized 
that genes that were up- or downregulated in Nnt−/− and 
their levels restored in NntBAC would be genes that were 
modulated by NNT.
NNT levels in the three mouse strains
Nnt expression levels in the three mouse strains were 
determined and while we observed very low mRNA levels 
in Nnt−/− mice (3.7-fold downregulation P = 0.012), there 
was a 2.7-fold (P = 1.8 × 10−5) increase in Nnt expression in 
NntBAC mice over that for Nnt+/+ (Fig. 6A). To investigate 
whether mRNA levels corresponded to protein expression 
we performed a Western blot on adrenal lysates from the 
same mice. NNT was undetectable in the Nnt−/− mice 
whereas a two-fold increase in NNT was observed in the 
adrenals of NntBAC mice, in keeping with the RNA-seq data 
(Fig. 6B). These results suggest that the NntBAC represents a 
modest Nnt overexpressor.
Figure 5
RNA-seq analysis flowchart and differential gene expression. 
(A) Flowchart of initial RNA-seq analysis of mouse adrenals. 
(B) Representative heat map of RNA-seq analysis for substrain-specific 
differentially expressed genes (between Nnt−/− and NntBAC) within mouse 
adrenals. Genes were clustered by Partek hierarchical clustering based on 
gene expression values. Normalisation was performed by genes shifted to 
mean of zero and scaled to s.d. of 1. Arbitrary signal intensity from 
RNA-seq data is represented by colours (red, higher expression, blue 
lower expression). (C) Venn diagram showing the number of differential 
genes in pairwise analyses between; Nnt+/+ vs Nnt−/− (187), Nnt−/− vs NntBAC 
(157) and Nnt+/+ vs NntBAC (141). Genes at the intersection of the pairwise 
analyses Nnt+/+ vs Nnt−/− and Nnt−/− vs NntBAC represent genes that are 
modulated by Nnt levels (39 + Nnt) (Table 1 and Supplementary Tables 3, 
4, 5, 6, 7 and 8).
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No differential expression of other genes with 
polymorphisms identified between substrains
Recently, comparative genomics between C57BL/6J 
and C57BL/6N strains has identified many SNPs and 
structural variants that may contribute to the phenotypic 
differences between the two strains (Simon et  al. 2013). 
To check whether these SNPs altered expression of these 
genes in the adrenal we specifically looked at their mRNA 
expression levels. Except for Cilp, which was up in NntBAC 
(1.6 fold over Nnt+/+ (P 0.013)) but unaltered between 
Nnt+/+ and Nnt−/−, we found no alterations in expression 
levels of the genes with interstrain variations, suggesting 
that the effects we describe are largely due to differential 
Nnt levels.
No differential expression of zone specific genes 
between substrains
Many genes show differential expression between the 
zones of the adrenal, classically for example tyrosine 
hydroxylase (Th), aldosterone synthase (Cyp11b2), 3-beta-
hydroxysteroid dehydrogenase (Hsd3b2), cytochrome 
b5 (Cyb5) and aldo-keto reductase family 1 member C3 
(Akr1c3). More recently transcriptomic analyses have 
identified hundreds of other genes with differential 
expression between ZF and ZG (Nishimoto et  al. 2012, 
Rege et al. 2014). None of these genes showed differential 
expression in our study suggesting no major remodelling 
of adrenals glands in Nnt−/− or NntBAC mice.
Nnt deletion does not alter the levels of ACTH 
receptor pathway genes or other genes associated 
with adrenal insufficiency
Mc2r expression was unaltered between Nnt+/+ vs Nnt−/− 
but up in NntBAC vs Nnt−/− (1.6-fold P = 0.023) whereas Mrap 
levels were the same across the 3 groups (data not shown). 
No significant expression level changes were observed at 
RNA level for other genes causing adrenal insufficiencies 
in humans (Aaas, Abcd1, Aire, Cdkn1c, Cyp11a1, Cyp11b1, 
Cyp17a1, Cyp21a1, Mcm4, Nr5a1, Por and Txnrd2).
Nnt deletion alters antioxidant gene levels
Nnt provides a constant supply of NADPH required for ROS 
detoxification by the thioredoxin and glutathione systems. 
Malic enzyme 3 (Me3) and isocitrate dehydrogenase 2 
(Idh2) are alternate NADPH suppliers although NNT 
is the major contributor (14). To investigate whether 
Nnt deletion leads to perturbation of other antioxidant 
enzymes perhaps to compensate for its loss, we looked 
at the mRNA and protein levels of antioxidant enzymes 
in these pathways. There was a modest reduction in gene 
expression levels of the antioxidants Prdx3 and Txnrd2 
which did not reach statistical significance, however 
at the protein level they were significantly reduced in 
Nnt−/− mice vs Nnt+/+ and the levels remained significantly 
low in NntBAC when compared to Nnt+/+ (Fig. 6C and D). 
This is likely because NntBAC overexpress NNT which 
may also cause redox imbalance, implying fine tuning 
Figure 6
Effect of NNT loss on redox homeostasis. 
(A) mRNA Nnt levels in the three mouse strains. 
(B) No NNT protein expression was observed in 
Nnt−/− (Western blot) however there was a 
two-fold upregulation in NntBAC when compared 
to Nnt+/+. (C) Protein levels of TXNRD2, PRDX3 
and GPX1 in the Nnt+/+, Nnt−/− and NntBAC mouse 
adrenals were normalised to actin with 
representative Western blots shown to the right.
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of NNT is required for redox homeostasis. We observed 
no compensatory increase in the alternative NADPH 
suppliers Me3 or Idh2.
Nnt deletion alters mitochondrial cytochrome 
P450scc levels
STAR is a protein involved in the transport of cholesterol 
from the outer to the inner mitochondrial membrane 
and specific partial loss-of-function mutations in STAR 
account for 10% of FGD cases (Meimaridou et al. 2013). 
Similarly, “mild” mutations in the cholesterol side chain 
cleavage enzyme (CYP11A1, the first enzyme in the steroid 
pathway), can give rise to FGD (Rubtsov et  al.  2009, 
Parajes et  al. 2011, Sahakitrungruang et  al. 2011). 
Mutations in 11β-hydroxylase (CYP11B1, the last enzyme 
in the glucocorticoid pathway) cause congenital adrenal 
hyperplasia. Previous work revealed that oxidative stress, 
resulting from the application of exogenous ROS, lead to 
inhibition of STAR protein expression and steroidogenesis 
in MA-10 Leydig cells, with no effect on CYP11A1 (Diemer 
et al. 2003). We hypothesized that a similar phenomenon 
might occur with endogenous mitochondrial oxidative 
stress resulting from NNT deficit affecting Star and/or 
the mitochondrial CYP450 enzymes, Cyp11a1 and 
Cyp11b1/b2. RNA-seq and Western blot analysis showed 
no significant changes in the expression of Star at mRNA 
or protein level, indicating that a defect in cholesterol 
Figure 7
Effect of NNT loss on steroidogenesis. (A) mRNA 
and protein fold change of enzymes involved in 
glucocorticoid synthesis, starting from cholesterol 
transport (STAR), to the first step of steroid 
synthesis (mitochondrial CYP11A1), and 
subsequent reactions catalysed by microsomal 
enzymes (HSD3B2, CYP21A1) to the final synthesis 
of corticosterone. (B) The conversion of 
cholesterol to corticosterone in mice is achieved 
by a series of catalytic reactions catalysed by 
mitochondrial (in blue) and microsomal (in pink) 
enzymes (right panel). (C) Panel of Western blots 
representing changes in expression of protein 
involved in steroidogenesis. Results are 
means ± standard deviation (s.d.); n = 5 mice per 
group, *P < 0.05, **P < 0.01, ***P < 0.001.
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transport due to oxidative insult is an unlikely mechanism 
(Fig.  7A and C). However, a suggestive 25% decrease in 
Cyp11a1, Cyp11b1 and Cyp11b2 mRNA levels in Nnt−/− mice 
with incomplete recovery in NntBAC suggested a possible 
mechanism for steroid depletion. In agreement with this 
we observed a 65% reduction in CYP11A1 at protein level 
in Nnt−/− and partial restoration (to approx. 50% of Nnt+/+ 
levels) in NntBAC (Fig. 7A and C). We were unable to assess 
CYP11B1/B2 levels since no specific murine antibody 
exists. The failure to completely recover Cyp11a1 levels in 
the NntBAC mice may be due to redox imbalance in these 
overexpressing mice and, significantly, protein abundance 
mirrors the levels of corticosterone in the three mouse 
substrains (Figs  3A and 7A). This is analogous to partial 
loss-of-function mutations in CYP11A1, which give rise 
to adrenal insufficiency in humans; the proteins may 
retain 30–40% of wild-type activity this is insufficient to 
maintain normal cortisol production (Parajes et al. 2011).
In contrast the intermediate steps of steroidogenesis 
occur in the ER, once pregnenolone is synthesized it 
undergoes reactions catalysed by 3β-hydroxysteroid 
dehydrogenase (Hsd3b2) and 21-hydroxylase (Cyp21a1) 
to produce progesterone and deoxycorticosterone 
respectively (Fig. 7B). No significant changes were observed 
at mRNA or protein level in these enzymes between Nnt−/− 
vs Nnt+/+ mice, suggesting that mitochondrial ROS does 
not affect them and that a reduction of these enzymes is 
not the reason for their corticosterone deficiency (Fig. 7A 
and C).
Transcriptomics-differentially expressed genes
In total 400 genes were differentially expressed in pairwise 
analyses between the mouse substrains (Supplementary 
Table  2). Differentially expressed genes between Nnt+/+ 
vs Nnt−/− numbered 187 (89 up and 98 downregulated), 
between Nnt−/− vs NntBAC numbered 157 (130 up- and 37 
downregulated) and between Nnt+/+ vs NntBAC numbered 
141 (119 up- and 22 downregulated) (Supplementary 
Tables 3, 4, 5, 6, 7 and 8).
We hypothesized that genes with altered expression 
in Nnt−/− that reverted to wild-type levels in the NntBAC 
would be genes that were modulated by Nnt levels. 40 
genes including Nnt were altered in Nnt−/− with their 
expression levels rescued in NntBAC. 23 of these were 
downregulated in Nnt−/− and back up in NntBAC, while 
17 were upregulated in Nnt−/− and back down in NntBAC 
(Table 1). Two groups of genes were enriched in this list; 
chaperones and haemoglobins. Specifically, there was 
a 25-fold increase in Hspa1a and Hspa1b in Nnt−/− mice, 
Table 1 Forty genes modulated by NNT levels.
Genes downregulated in Nnt−/− and restored in NntBAC
Gene ID Gene description
1500015O10Rik RIKEN cDNA 1500015O10 gene
9330151L19Rik ENSMUSG00000097061 – uncharacterized 
protein
A530020G20Rik RIKEN cDNA A530020G20 gene
C1qtnf6 C1q and tumour necrosis factor related 
protein 6
Ccdc160 Coiled-coil domain containing 160
Ctxn3 Cortexin 3
Cyp21a2-ps Cyp21a2 pseudogene
E330017L17Rik RIKEN cDNA E330017L17 gene
Epb4.1l4aos Erythrocyte membrane protein band 4.1 
like 4a, opposite strand
Gnat2 Guanine nucleotide binding protein, alpha 
transducing 2
Ism1 Isthmin 1 homolog (zebrafish)
Kcnn2 Potassium intermediate/small conductance 
calcium-activated channel, subfamily N, 
member 2
Lilr4b Leukocyte immunoglobulin-like receptor, 
subfamily B, member 4B
Ly96 Lymphocyte antigen 96
Nnt Nicotinamide nucleotide transhydrogenase
Pacsin3 Protein kinase C and casein kinase substrate 
in neurons 3
Sox12 SRY-box containing gene 12
Steap1 Six transmembrane epithelial antigen of 
the prostate 1
Trim12c Tripartite motif-containing 12C
Trim21 Tripartite motif-containing 21
Trim30d Tripartite motif-containing 30D
Tuft1 Tuftelin 1
Vsnl1 Visinin-like 1
Genes upregulated in Nnt−/− and restored in NntBAC
Arl4d ADP-ribosylation factor-like 4D
Cwc25 CWC25 spliceosome-associated protein 
homolog (S. cerevisiae)
Cyr61 Cysteine rich protein 61
Dnajb1 DnaJ (Hsp40) homolog, subfamily B, 
member 1
Egr1 Early growth response 1
Fam46a Family with sequence similarity 46, member 
A
Gadd45g Growth arrest and DNA-damage-inducible 
45 gamma
Hba-a1 Hemoglobin alpha, adult chain 1
Hba-a2 Hemoglobin alpha, adult chain 2
Hbb-bs Hemoglobin, beta adult s chain
Hbb-bt Hemoglobin, beta adult t chain
Ier2 Immediate early response 2
Ier3 Immediate early response 3
Irs2 Insulin receptor substrate 2
Klf4 Kruppel-like factor 4 (gut)
Nr4a2 Nuclear receptor subfamily 4, group A, 
member 2
Zfp36l2 Zinc finger protein 36, C3H type-like 2
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and these levels were restored to Nnt+/+ levels in the NntBAC 
mice. A smaller, but still significant, increase was observed 
in another heat shock (Hspb1) and a co-chaperone 
(Dnajb1) in Nnt−/− mice (Fig. 8A).
The upregulation of heat shock proteins suggests that 
proteins are undergoing damage due to increased ROS 
and the molecular chaperone machinery is activated to 
correct or degrade such damaged or misfolded proteins. 
Interestingly alpha- and beta-haemoglobins (Hba-a1, 
Hba-a2, Hbb-b1 and Hbb-b2 (aka Hbb-bs and Hbb-bt)) 
were 4 to 5-fold upregulated in Nnt−/− mice (P < 0.025) 
and their levels returned to normal in NntBAC (Fig. 8B). 
Erythroid contamination of the tissues from Nnt−/− 
mice was considered but ruled out as other genes highly 
expressed in the development of erythroid lineages 
were not significantly upregulated (51 genes from 
An et al. 2014). Recently the expression of haemoglobins 
in tissues other than erythrocytes has been reported 
suggesting their role in other basic cellular functions 
apart from O2 transport (Fordel et al. 2006, Vinogradov 
& Moens 2008).
Discussion
We have previously shown that mutations in NNT cause 
adrenal dysfunction in humans primarily affecting the 
ZF cells of the adrenal cortex responsible for cortisol 
production, and observed a 50% reduction in corticosterone 
levels in 3-month-old Nnt null mice (Meimaridou et  al. 
2012). Further, we showed mitochondrial perturbations 
and limited antioxidant capacity in human adrenocortical 
carcinoma cells where NNT expression was stably 
knocked down (Meimaridou et  al. 2012). In this study, 
we investigated the mechanism by which NNT affects 
steroidogenesis in older mice by utilising three models 
with differing expression levels of Nnt; wild-type Nnt+/+, 
null Nnt−/− and two-fold overexpressing NntBAC mice. 
Gene expression and Western blotting analysis revealed 
restricted levels of key mitochondrial antioxidant 
and steroidogenic proteins in Nnt−/− mice leading to 
glucocorticoid deficiency, which was partially rescued in 
the overexpressing mice. Interestingly, we demonstrate for 
the first time that overexpression of Nnt also negatively 
impacts steroidogenesis; this may be due to a persistent 
redox imbalance initiated by the oversupply of NADPH 
by NNT.
The mouse inbred C57BL/6 strain is widely used for 
genetic and functional studies. There are two substrains 
of these mice depending on their site of origin; C57BL/6J 
established in Jackson laboratory and C57BL/6N line 
from the National Institutes of Health (NIH). In 2005, a 
spontaneous loss-of-function Nnt mutation in C57BL/6J 
was characterised, which was associated with impaired 
glucose tolerance (Ronchi et al. 2016). Since then, these 
mice have been used to clarify the roles of NNT in 
mammalian biology.
More recently, comparative genomics between 
C57BL/6J and C57BL/6N strains has identified many 
SNPs and structural variants that may contribute to the 
phenotypic differences between the two strains (24). We 
compared expression levels of the genes noted in this 
publication but revealed no differences in mRNA levels 
exception for Nnt. This suggests that the transcriptome 
changes and the endocrine phenotype observed in Nnt−/− 
mice is largely due to differential NNT levels.
Figure 8
Enrichment of gene pathways in response to oxidative stress. (A) mRNA 
levels of heat shock proteins revealed significant upregulation (Hspa1a 
26-fold; Hspa1a 25-fold; Hsph1 3-fold; Dnajb1 6-fold) in Nnt−/− mice and 
restoration of the levels in NntBAC mouse adrenals. (B) Similarly 
haemoglobin gene mRNA expression was significantly upregulated in 
Nnt−/− mice when compared to Nnt+/+ and reversed in NntBAC (Hbb-b1 
4-fold; Hbb-b2 5-fold; Hba-a1 5-fold; Hba-a2 5-fold).
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In this study, we have employed, in addition, a mouse 
strain with transgenic rescue of Nnt expression (NntBAC) 
(Freeman et al. 2006). The Nnt replacement has previously 
been shown to induce improvements in glucose tolerance 
and insulin secretion rescuing the phenotype seen in 
Nnt−/− mice. Corticosterone levels recovered somewhat 
in the NntBAC; however, they remained significantly lower 
than wild-type levels.
In this in vivo model, we also showed that the 
antioxidant capacity of the Nnt−/− adrenals is significantly 
compromised when compared to Nnt+/+ counterparts. 
The protein levels of key mitochondrial antioxidant 
enzymes PRDX3 and TXNRD2 are significantly reduced 
in Nnt−/− mice and fail to recover in NntBAC. This strongly 
suggests that a set level of Nnt expression is required to 
maintain mitochondrial redox homeostasis. Furthermore, 
since mitochondrial NADPH can be regenerated not 
only by Nnt, but also by isocitrate dehydrogenase 2 
(Idh2) and malic enzyme 3 (Me3), we excluded a possible 
compensatory mechanism, as expression levels of these 
enzymes remain unchanged between Nnt+/+ and Nnt−/− 
mice. Studies by other groups have similarly demonstrated 
that liver, heart, brain and skeletal muscle mitochondria 
from Nnt−/− mice have unaltered Idh2 and Me3 enzymatic 
activities meaning they cannot compensate for the loss of 
NNT to restore NADPH levels (Nickel et al. 2015, Ronchi 
et al. 2016). When NNT is ablated in human adrenocortical 
cells, we also see a disturbance of redox balance, but 
here this does not affect cortisol output, perhaps due to 
adaptive alterations in sulfiredoxin and peroxiredoxin 
III levels, which are known to occur in H295R cells, and 
even primary adrenocortical cells, when grown in culture 
(Kil et al. 2013).
NNT dysregulation not only affects the antioxidant 
capacity of the adrenal but also its steroidogenic 
capacity. We demonstrated that, in Nnt−/− mice, adrenal 
steroidogenesis is severely affected (86% reduction in 
corticosterone in 18  months old mice), due to the low 
protein levels of a crucial steroidogenic enzyme, CYP11A1. 
Interestingly, NntBAC mice also exhibit glucocorticoid 
deficiency as indicated by 60% reduction in levels of 
corticosterone suggesting that Nnt overexpression also 
impacts on the steroidogenic output of these mice. It 
is increasingly recognised that redox balance is key to 
physiological health. Where one might assume that 
underexpression of antioxidants would lead to oxidative 
stress and overexpression would give reductive stress; 
this is not necessarily what occurs in vivo (reviewed in 
Lei et al. 2016), with clear examples of antioxidant gene 
knockdown inducing reductive stress (Yan et al. 2017) and 
antioxidant gene overexpression also causing reductive 
stress (Zhang et al. 2010). In addition, paradoxically, both 
reductive and oxidative insult can lead to overproduction 
of ROS (Barrett et  al. 2004, Arrigo et  al. 2005, Filomeni 
et  al. 2005, Ali et  al. 2014, Yu et  al. 2014, Korge et  al. 
2015), which can cause protein damage. We suggest 
that this may be the explanation for the failure to rescue 
glucocorticoid secretion in the overexpressing mice with 
the demonstration of higher levels of lipid peroxidation 
in the NntBAC mice compared to Nnt+/+ mice lending 
support to this.
Differential gene expression studies between 
Nnt+/+ and Nnt−/− revealed a significant upregulation 
of heat shock proteins in Nnt−/− mice. The failure of 
ROS detoxification may lead to oxidative damage of 
proteins and the canonical chaperone machinery will be 
upregulated to cope with the resultant protein misfolding 
and degradation. The increased ROS will also render cells 
more susceptible to apoptosis but heat shock proteins 27 
and 70 (Hsp27 and Hsp70 respectively) are activated by 
mitochondrial ROS and are protective of cells preventing 
apoptosis by replenishing reduced glutathione and 
reducing intracellular iron levels (Barrett et  al. 2004, 
Arrigo et al. 2005, Filomeni et al. 2005).
In addition to heat shock protein machinery, we 
show haemoglobins are regulated by NNT levels. There is 
a significant increase in the mRNA levels of haemoglobins 
in Nnt−/− mice possibly as a compensatory mechanism 
to combat oxidative stress. Haemoglobins are composed 
of alpha and beta HbA chains and their accepted 
main function is to transport O2 to cells thorough the 
vascular network. However, their involvement in other 
fundamental cellular functions and in non-erythroid 
cells is increasingly being recognised. Detection of 
haemoglobin chains in macrophages, alveolar cells, 
kidney, brain and vaginal epithelial cells has been reported 
and their function has been linked with antioxidant 
defence and the regulation of mitochondrial activity (Liu 
et al. 1999, Arrigo et al. 2005, Newton et al. 2006, Nishi 
et al. 2008, Saha et al. 2017). In adrenal, overexpression of 
α-Hb in rat phaeochromocytoma (PC12) cells resulted in 
downregulation of Gpx1 and Sod1 mRNAs suggesting that 
it may have a role in the scavenging of ROS (Biagioli et al. 
2009, Maria et  al. 2012). Whether a similar mechanism 
explains the upregulation we see in intact adrenals 
requires further investigation.
In this study, we showed that the reduced steroidogenic 
capacity of the adrenals in Nnt−/− and NntBAC mice is due to 
the inability of other antioxidant enzymes to compensate 
for redox imbalance resulting from altered Nnt levels. 
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This leads to limited availability of mitochondrial CYP11A1 
and a reduction in corticosterone output. Recently a 
similar mechanism was demonstrated to underlie the 
adrenal dysfunction seen in Triple A, a disorder of adrenal 
insufficiency, alacrima and achalasia due to mutations 
in AAAS encoding the protein ALADIN. A deficiency of 
ALADIN results in cytosolic, as opposed to mitochondrial, 
oxidative stress and a deficit of microsomal, rather than 
mitochondrial, CYP450 enzymes thereby retarding adrenal 
steroidogenesis (Juhlen et al. 2015).
Conclusions
Using transcriptomic profiling in adrenals from three 
mouse substrains, we showed that disturbances in 
adrenal redox homeostasis are mediated not only by 
under expression of NNT but also by its overexpression. 
Further, we demonstrated that both underexpression 
or overexpression of NNT reduces corticosterone 
output implying a central role for it in the control of 
steroidogenesis. Reduced expression of CYP11A1, a 
key mitochondrial steroidogenic enzyme, mirrored 
the reduction in corticosterone output. Our data also 
suggest that oxidative stress and/or ROS damage to 
proteins is activating mito- and cytoprotective proteins 
(haemoglobins and heat shock proteins respectively) that 
may help maintain cell viability but do not rescue the 
steroidogenic phenotype.
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